BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

Single Use Support Launches Next-Generation RoSS.BLST Platform for Scalable Freeze-Thaw Bioprocessing

Single Use Support introduces the advanced RoSS.BLST, a blast freezing and thawing platform designed to deliver maximum process consistency and product qua...

June 18, 2026 | News

Gesynta Pharma Reaches 50% Patient Enrollment in Phase II Endometriosis Trial of Vipoglanstat

Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic inflammatory diseases, today announced that 50% of the target of 190...

June 18, 2026 | News

Pelago Bioscience Acquires RG Discovery to Create Integrated Chemistry-to-Biology Drug Discovery Platform

Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement as...

June 17, 2026 | News

QIAGEN Bets Big on Digital PCR with Major QIAcuity Ecosystem Expansion

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology applic...

June 16, 2026 | News

Thermo Fisher Scientific Simplifies Nucleic Acid Verification With New E Gel Power Snap Lite System

Thermo Fisher Scientific announced the launch of the Invitrogen™ E-Gel™ Power Snap Lite Electrophoresis System, a compact, all-in-one solution ...

June 03, 2026 | News

Samsung Bioepis Launches OPUVIZ Aflibercept Biosimilar Across Europe

OPUVIZ™ 40 mg/mL solution for injection in a vial, a biosimilar referencing Eylea (aflibercept), will be rolled out across Europe, starting today...

June 01, 2026 | News

Leica Biosystems Expands AstraZeneca And Daiichi Sankyo Collaboration To Advance AI Driven Lung Cancer Biomarker Research

Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions,announced an expansion of its strategic coll...

June 01, 2026 | News

Antengene Receives CDE Endorsement For Pivotal Phase III Study Of CLDN18.2 ADC In Gastric Cancer

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, d...

May 29, 2026 | News

Ribo Submits Phase 2 CTA To EMA For siRNA Therapy Targeting Coronary Artery Disease

Suzhou Ribo Life Science (stock code 06938.HK) and Ribocure Pharmaceuticals (together "Ribo") announce the submission of Phase 2 Clinical Trial Application...

May 29, 2026 | News

CordenPharma Expands Global Peptide Manufacturing Network Through AmbioPharm Acquisition

Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs CordenPharma has entered into...

May 28, 2026 | News

Stryker Launches Pangea Plating System In Europe To Advance Fracture Fixation Workflows

Stryker (NYSE:SYK), a global leader in medical technologies, announced the European launch of its Pangea Plating System, a plating platform for the tr...

May 27, 2026 | News

Pierre Fabre Laboratories Receives CHMP Positive Opinion For BRAFTOVI Combination In First Line BRAF Mutant Metastatic Colorectal Cancer

This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination w...

May 27, 2026 | News

AGC Biologics Selected By Teikoku Seiyaku Co., Ltd. To Advance Microbial Manufacturing For KTP 001 Disc Herniation Therapy

AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co., Ltd., a leader in transdermal drug delivery, to provide microbial contract d...

May 27, 2026 | News

Allergan Aesthetics Receives Positive CHMP Opinion For Boey Across Europe

Boey® has received a positive opinion from the CHMP for 30 EU & EEA markets If approved, Boey® has the potenti...

May 25, 2026 | Regulatory

Stay Connected